BioSpace News Archive

CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.

The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).

For people suffering from severe depression, the road to remission just became a lot shorter: The treatment is known as Transcranial Magnetic Stimulation (TMS), and MagVenture has now, as the only TMS provider in the US, received FDA clearance for a newer and much faster treatment protocol which will cut down treatment time to just 3 minutes per session*.

Pennsylvania-based medical practice increases diabetic retinal exam compliance rate to 85% from 37% in first year

Leading Healthcare IT Vendors Collaborate to Address Medical Device Security

Sound Affects announces strategic partnership with Vevo, the world’s leading music video and entertainment platform.

Benson Hill Biosystems, a crop improvement company unlocking the natural genetic diversity of plants, and Agribody Technologies, Inc., an emerging agricultural biotechnology company, are partnering to deliver non-GMO yield and sustainability traits for seed companies working in corn,

The Renewal Center is pleased to announce they now offer GAINSWave!

Active Ingredient in SGX301 for the Treatment of Cutaneous T-Cell Lymphoma

Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo Securities 2018 Healthcare Conference at the Westin Copley Place in Boston, MA, Wednesday, September 5, 2018 at 4:10 p.m. (ET).